{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:21:16Z","timestamp":1777983676409,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009131","name":"Direktion f\u00fcr Entwicklung und Zusammenarbeit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.dld.2021.06.034","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:11:53Z","timestamp":1626977513000},"page":"111-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serum bile acids in cystic fibrosis patients \u2013 glycodeoxycholic acid as a potential marker of liver disease"],"prefix":"10.1016","volume":"54","author":[{"given":"S\u0142awomira","family":"Drzyma\u0142a-Czy\u017c","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Dziedzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Szwengiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrycja","family":"Krzy\u017canowska-Jankowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Nowicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raisa","family":"Aringazina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Drzyma\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya","family":"Kashirskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Walkowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.06.034_bib0001","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/347358a0","article-title":"Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells","volume":"347","author":"Rich","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.dld.2021.06.034_bib0002","doi-asserted-by":"crossref","first-page":"e82297","DOI":"10.1371\/journal.pone.0082297","article-title":"A new method to improve the clinical evaluation of cystic fibrosis patients by mucus viscoelastic properties","volume":"9","author":"Tomaiuolo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2021.06.034_bib0003","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav3488","article-title":"Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis","volume":"11","author":"Esther","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.dld.2021.06.034_bib0004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MEG.0b013e3282f36d16","article-title":"The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype","volume":"20","author":"Walkowiak","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.06.034_bib0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5603\/ARM.2016.0040","article-title":"Long term outcome of cystic fibrosis patients with multisystem evaluation","volume":"84","author":"Hassanzad","year":"2016","journal-title":"Adv Respir Med"},{"key":"10.1016\/j.dld.2021.06.034_bib0006","series-title":"Comprehensive physiology","article-title":"Bile acid metabolism and signaling","author":"Chiang","year":"2013"},{"key":"10.1016\/j.dld.2021.06.034_bib0007","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.dld.2021.06.034_bib0008","first-page":"340","article-title":"Liver disease in children with cystic fibrosis","volume":"2","author":"Diwakar","year":"2001","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.dld.2021.06.034_bib0009","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jcf.2007.10.004","article-title":"A single centre experience of liver disease in adults with cystic fibrosis 1995-2006","volume":"7","author":"Nash","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.dld.2021.06.034_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000477913","article-title":"Serum phospholipid fatty acid composition in cystic fibrosis patients with and without liver cirrhosis","author":"Drzyma\u0142a-Czy\u017c","year":"2017","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.dld.2021.06.034_bib0011","first-page":"421","article-title":"Markers of cystic fibrosis-associated liver disease","volume":"32","author":"Narkewicz","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2021.06.034_bib0012","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.dld.2021.06.034_bib0013","first-page":"305","article-title":"Digestion and absorption of lipids","volume":"12","author":"Borgstr\u00f6m","year":"1977","journal-title":"Int Rev Physiol"},{"key":"10.1016\/j.dld.2021.06.034_bib0014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/14712598.2014.880420","article-title":"The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention","volume":"14","author":"Jones","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.dld.2021.06.034_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fendo.2019.00029","article-title":"Impact of Gut microbiota on host glycemic control","volume":"10","author":"G\u00e9rard","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.dld.2021.06.034_bib0016","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/j.gastro.2014.02.008","article-title":"Role of the microbiome in energy regulation and metabolism","volume":"146","author":"Nieuwdorp","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.06.034_bib0017","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.28.4.506-a","article-title":"Bile acid secretion in cystic fibrosis","volume":"28","author":"Davidson","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.06.034_bib0018","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/gut.27.9.1043","article-title":"Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption","volume":"27","author":"Weizman","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.06.034_bib0019","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/gut.26.11.1246","article-title":"Conjugated bile acids in serum and secretions in response to cholecystokinin\/secretin stimulation in children with cystic fibrosis","volume":"26","author":"Robb","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.06.034_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(96)80326-6","article-title":"Bile acid kinetics and biliary lipid composition in cystic fibrosis","volume":"25","author":"Strandvik","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.06.034_bib0021","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpeds.2016.05.008","article-title":"Long-term ursodeoxycholic acid therapy does not alter lithocholic acid levels in patients with cystic fibrosis with associated liver disease","volume":"177","author":"Colombo","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2021.06.034_bib0022","first-page":"1484","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian group for the study of ursodeoxycholic acid in cystic fibrosis","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.06.034_bib0023","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.dld.2021.06.034_bib0024","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pedi.12178","article-title":"Management of cystic fibrosis-related diabetes in children and adolescents: Management of cystic fibrosis-related diabetes","volume":"15","author":"Moran","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.dld.2021.06.034_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1569-1993(02)00096-6","article-title":"Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis","volume":"1","author":"Walkowiak","year":"2002","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.dld.2021.06.034_bib0026","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1651-2227.2004.tb02715.x","article-title":"Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis","volume":"93","author":"Walkowiak","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.dld.2021.06.034_bib0027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.advms.2018.04.001","article-title":"Vitamin E status and its determinants in patients with cystic fibrosis","volume":"63","author":"Sapiejka","year":"2018","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.dld.2021.06.034_bib0028","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2008.08.018","article-title":"Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC\u2013MS\/MS","volume":"873","author":"Alnouti","year":"2008","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.dld.2021.06.034_bib0029","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1039\/C4FO00946K","article-title":"Binding of bile acids by pastry products containing bioactive substances during in vitro digestion","volume":"6","author":"Dziedzic","year":"2015","journal-title":"Food Funct"},{"key":"10.1016\/j.dld.2021.06.034_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1641\/0006-3568(2001)051[0341:LNDATS]2.0.CO;2","article-title":"Log-normal distributions across the sciences: keys and clues","volume":"51","author":"Limpert","year":"2001","journal-title":"BioScience"},{"key":"10.1016\/j.dld.2021.06.034_bib0031","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MPG.0b013e3182432034","article-title":"Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease","volume":"54","author":"Pereira","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2021.06.034_bib0032","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5114\/pg.2013.38730","article-title":"Aetiopathogenesis of liver changes in the course of cystic fibrosis, considering disturbances of the bile acid profile as well as genetic and immunological factors","volume":"5","author":"Wi\u0119cek","year":"2013","journal-title":"Gastroenterol Rev"},{"key":"10.1016\/j.dld.2021.06.034_bib0033","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-1007159","article-title":"Liver and biliary problems in cystic fibrosis","volume":"18","author":"Colombo","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2021.06.034_bib0034","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.20238","article-title":"Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis","volume":"39","author":"Smith","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.06.034_bib0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MEG.0000000000000593","article-title":"Supplementation of ursodeoxycholic acid improves fat digestion and absorption in cystic fibrosis patients with mild liver involvement","volume":"28","author":"Drzyma\u0142a-Czy\u017c","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.dld.2021.06.034_bib0036","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bpg.2010.08.003","article-title":"Cystic fibrosis-associated liver disease","volume":"24","author":"Herrmann","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2021.06.034_bib0037","doi-asserted-by":"crossref","first-page":"G1411","DOI":"10.1152\/ajpgi.00181.2007","article-title":"Pathophysiological basis of liver disease in cystic fibrosis employing a F508 mouse model","volume":"294","author":"Freudenberg","year":"2008","journal-title":"AJP Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2021.06.034_bib0038","first-page":"544","article-title":"Bile acid biosynthesis and its regulation","volume":"64","author":"Hebanowska","year":"2010","journal-title":"Postep Hig Med Dosw (Online)"},{"key":"10.1016\/j.dld.2021.06.034_bib0039","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/138920008784220574","article-title":"Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis","volume":"9","author":"Lundell","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.dld.2021.06.034_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.dld.2021.06.034_bib0041","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0016-5085(00)70267-8","article-title":"Regulation of sterol 12alpha-hydroxylase and cholic acid biosynthesis in the rat","volume":"118","author":"Vlahcevic","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.06.034_bib0042","first-page":"501","article-title":"Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription","volume":"21","author":"Twisk","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.06.034_bib0043","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/oxfordjournals.jbchem.a022584","article-title":"Insulin is a dominant suppressor of sterol 12 alpha-hydroxylase P450 (CYP8B) expression in rat liver: possible role of insulin in circadian rhythm of CYP8B","volume":"127","author":"Ishida","year":"2000","journal-title":"J Biochem"},{"key":"10.1016\/j.dld.2021.06.034_bib0044","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11892-018-1020-6","article-title":"The gut microbiome as a target for the treatment of type 2 diabetes","volume":"18","author":"Aydin","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.dld.2021.06.034_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.17.4.295","article-title":"Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis","volume":"17","author":"Weber","year":"1976","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.06.034_bib0046","first-page":"556","article-title":"Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency","volume":"3","author":"Colombo","year":"1984","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2021.06.034_bib0047","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/j.gastro.2018.10.047","article-title":"Impaired exocrine pancreatic function associates with changes in intestinal microbiota composition and diversity","volume":"156","author":"Frost","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.06.034_bib0048","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbrc.2017.10.130","article-title":"Supplementation of pancreatic digestive enzymes alters the composition of intestinal microbiota in mice","volume":"495","author":"Nishiyama","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2021.06.034_bib0049","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.dld.2021.06.034_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193824","article-title":"Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2021.06.034_bib0051","first-page":"631","article-title":"Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection","volume":"56","author":"Lisowska","year":"2009","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.dld.2021.06.034_bib0052","doi-asserted-by":"crossref","first-page":"345","DOI":"10.18388\/abp.2011_2244","article-title":"Antibiotic therapy and fat digestion and absorption in cystic fibrosis","volume":"58","author":"Lisowska","year":"2011","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.dld.2021.06.034_bib0053","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.mpg.0000178439.64675.8d","article-title":"Gastrointestinal outcomes and confounders in cystic fibrosis","volume":"41","author":"Borowitz","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2021.06.034_bib0054","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2011.06.008","article-title":"Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth","volume":"10","author":"Lisowska","year":"2011","journal-title":"J Cyst Fibros"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821003704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821003704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:18:51Z","timestamp":1761625131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821003704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1590865821003704"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.06.034","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum bile acids in cystic fibrosis patients \u2013 glycodeoxycholic acid as a potential marker of liver disease","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}